Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2004

PHARMANIAGA BERHAD

Quarterly report for the financial period ended

30/09/2004
Quarter3
Financial Year End31/12/2004
The figureshave not been audited

Attachments

pharma_klse0409_final.doc
383 KB

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2004


INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR CORRESPONDING QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR CORRESPONDING PERIOD
30/09/2004 
30/09/2003 
30/09/2004 
30/09/2003 
 
 
 
 
RM'000
RM'000
RM'000
RM'000
1Revenue
229,265
156,200
599,214
465,987
2Profit/(loss) before tax
22,581
16,917
59,514
48,177
3Profit/(loss)
after tax and minority
interest
14,201
11,226
37,467
31,261
4Net profit/(loss) for
the period
14,201
11,226
37,467
31,261
5Basic earnings/(loss) per share (sen)
13.99
11.21
37.06
31.24
6Dividend per share (sen)
0.00
0.00
0.00
0.00



AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net tangible assets per share (RM)

2.5300
2.2200

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my



Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced26 Nov 2004  
CategoryFinancial Results
Reference NoCC-041126-51E6F